Chemical Characteristics and Structure
Structurally, azoximer bromide is a high-molecular-weight compound. It is important not to confuse it with low-molecular-weight substances or imidazole derivatives: its polymeric nature determines the unique pharmacological properties of the drug and its specific interactions with the immune system.
Key Pharmacological Effects
The drug's action is based on two main directions:
- Immunomodulating activity — targeted correction and stimulation of host defense mechanisms.
- Detoxifying action — clearing the body of toxic agents.
Mechanism of Action and Sites of Action
The pharmacological response develops through the activation of factors of natural nonspecific resistance. The drug engages the following cellular structures:
- cells of the mononuclear phagocyte system;
- neutrophils;
- natural killer cells (NK cells).
Clinically significant feature: the medication increases the functional activity of these cells exclusively when their baseline parameters are depressed, avoiding excessive hyperstimulation of a normal immune system.
Indications for Use and Limitations
The clinical scope of Polyoxidonium covers a wide range of pathological and somatic conditions:
- treatment and prevention of secondary immunodeficiency states;
- local and generalized infectious processes;
- immune system damage caused by ionizing radiation, cytostatics, or glucocorticosteroid therapy;
- post-traumatic periods following injuries, surgeries, and burns.
Contraindications: the use of the drug is strictly prohibited during pregnancy.